GleamWall
中文EN

ECVT Ecovyst Inc.

Chemicals & Allied Products · NYSE · SEC CIK 1708035 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY44.6%
TTM net income YoY133.6%
TTM EPS YoY134.4%
Revenue 3-yr CAGR11.5%
Net income 3-yr CAGR-18.4%

Margins

Gross margin19.7%
Operating margin8.5%
Net margin3.7%
FCF margin2.8%
EBITDA margin15.9%

Returns

ROE5.9%
ROA2.3%
ROIC (approx.)5.4%
Asset turnover0.62x

Leverage & solvency

Liabilities / assets57.2%
Debt / equity0.81x
Current ratio1.82x
Interest coverage3.73x

Cash quality & payout

Operating cash flow / net income3.28x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue9.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$723.51M$598.29M$584.85M$820.16M$611.20M
Cost of revenue$565.43M$434.91M$418.40M$595.53M$434.54M
Gross profit$158.09M$163.38M$166.45M$224.63M$176.66M
R&D expense—$6.81M$7.80M$7.23M$7.50M
SG&A expense$66.02M$65.39M$60.53M$85.33M$97.78M
Operating income$64.89M$85.13M$89.55M$104.39M$54.61M
Interest expense$34.20M$36.49M$31.70M$37.22M$36.99M
Pretax income$25.79M$45.20M$56.95M$94.73M$13.94M
Income tax$19.50M-$299,000$8.73M$24.94M$12.15M
Net income-$71.13M-$6.65M$71.15M$73.70M-$139.95M
EBITDA$132.69M$145.00M$144.90M$183.55M$134.35M
EPS (basic)-0.62-0.060.600.55-1.03
EPS (diluted)-0.61-0.060.600.55-1.02
Dividends declared per share————3.20
Weighted avg. shares (diluted)115.96M117.45M119.49M135.09M137.71M
Balance sheet
Cash & equivalents$197.19M$131.39M$72.65M$110.92M$140.89M
Receivables$85.31M$53.20M$81.31M$74.76M$80.80M
Inventory$26.80M$17.97M$45.12M$44.36M$53.81M
Current assets$319.36M$303.71M$245.99M$267.70M$291.67M
PP&E, net$481.16M$458.68M$576.90M$584.89M$596.23M
Goodwill$326.74M$326.59M$404.47M$403.16M$406.14M
Intangibles$59.29M$67.70M$116.55M$129.93M$145.62M
Total assets$1.26B$1.80B$1.84B$1.88B$1.93B
Current liabilities$120.81M$115.13M$119.08M$129.40M$145.08M
Short-term debt$0$8.73M$9.00M$9.00M$9.00M
Long-term debt$392.58M$852.10M$858.95M$865.87M$872.84M
Total debt$392.58M$860.83M$867.95M$874.87M$881.84M
Total liabilities$657.54M$1.10B$1.13B$1.18B$1.19B
Shareholders' equity$603.44M$700.46M$705.46M$707.23M$740.74M
Net debt$195.39M$729.44M$795.30M$763.95M$740.95M
Shares outstanding111.81M116.53M116.12M122.19M136.94M
Cash flow statement
Operating cash flow$140.31M$149.89M$137.60M$186.61M$129.92M
Capital expenditure$70.41M$55.59M$59.04M$58.87M$60.05M
Free cash flow$69.89M$94.30M$78.56M$127.74M$69.87M
Investing cash flow$435.41M-$73.45M-$65.33M-$63.02M$835.73M
Financing cash flow-$524.96M-$17.84M-$93.50M-$148.19M-$964.23M
Depreciation & amortization$67.81M$59.86M$55.34M$79.16M$79.74M
Stock-based compensation$9.75M$11.13M$12.98M$20.63M$31.84M
Dividends paid——$0$0$435.59M
Share buybacks$46.95M$5.01M$78.72M$136.74M$0

Free plan shows the latest 5 periods; Pro shows all 11 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.